BridgeBio Pharma LLC - 11 Aug 2025 SCHEDULE 13D Report for BridgeBio Oncology Therapeutics, Inc. Common Stock, $0.0001 par value

Filing Manager: BridgeBio Pharma LLC
Reporting Manager: BridgeBio Pharma LLC
Security: BridgeBio Oncology Therapeutics, Inc. Common Stock, $0.0001 par value
Shares outstanding: 79,306,023 shares
Disclosed Ownership: 13,878,554 shares
Ownership: 18%
Form type: SCHEDULE 13D
Filing time: 18 Aug 2025, 17:41:28 UTC
Date of event: 11 Aug 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BridgeBio Pharma LLC	18%	13,878,554	13,878,554	0	/s/ Neil Kumar	Neil Kumar, Chief Executive Officer	0002076615
BridgeBio Pharma, Inc.	18%	13,878,554	13,878,554	0	/s/ Neil Kumar	Neil Kumar, Chief Executive Officer	0001743881